Phase I study of EST, a new thiol protease inhibitor. The 2nd report: Safety and pharmacokinetics in continuous administration.
- 1 January 1985
- journal article
- Published by Japanese Society of Clinical Pharmacology and Therapeutics in Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics
- Vol. 16 (3), 537-546
- https://doi.org/10.3999/jscpt.16.537